http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014055507-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42053d4f517feab5a9bb4b92ece8256e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0526
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0529
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0492
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2013-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd6fa645bd3d00549f8e2f40b6bdb844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_796ec8b212b2f1f6cd888447d5fe1820
publicationDate 2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014055507-A2
titleOfInvention WEARABLE, UNSUPERVISED TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) DEVICE FOR MOVEMENT DISORDER THERAPY, AND METHOD OF USING
abstract The present invention relates to a system and methods for noninvasively providing therapy for movement disorder symptoms. The present invention provides such a therapy system which provides trans-cranial direct current stimulation (tDCS) in order to treat those symptoms and the disorders. The present invention further provides such tDCS therapy while the subject sleeps in order to minimize the time required and impact of the therapy on the subject's waking life. The system, methods, and devices of the present invention are intended to provide a low-dose electrical current, trans-cranially, to a specific area of the subject's brain while he or she sleeps in order to decrease the occurrence, severity, and duration of the symptoms of movement disorders. The present invention aims to reduce the amount of medication necessary, counteract the effects of medication wearing off during sleep, and to overall improve the quality of life of subjects suffering from movement disorders.
priorityDate 2012-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008045775-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25674
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14654
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID52152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID52152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670

Total number of triples: 31.